192 related articles for article (PubMed ID: 9922304)
1. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.
Taha AS; Dahill S; Morran C; Hudson N; Hawkey CJ; Lee FD; Sturrock RD; Russell RI
Gastroenterology; 1999 Feb; 116(2):254-8. PubMed ID: 9922304
[TBL] [Abstract][Full Text] [Related]
2. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.
Kobata Y; Yajima H; Yamao J; Tanaka Y; Fukui H; Takakura Y
Mod Rheumatol; 2009; 19(6):629-36. PubMed ID: 19728013
[TBL] [Abstract][Full Text] [Related]
4. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
5. Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis.
Yajima H; Yamao J; Fukui H; Takakura Y
J Orthop Sci; 2007 Jul; 12(4):341-6. PubMed ID: 17657553
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
8. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
Chan FK; To KF; Wu JC; Yung MY; Leung WK; Kwok T; Hui Y; Chan HL; Chan CS; Hui E; Woo J; Sung JJ
Lancet; 2002 Jan; 359(9300):9-13. PubMed ID: 11809180
[TBL] [Abstract][Full Text] [Related]
9. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
10. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.
Hudson N; Taha AS; Russell RI; Trye P; Cottrell J; Mann SG; Swanell AJ; Sturrock RD; Hawkey CJ
Gastroenterology; 1997 Jun; 112(6):1817-22. PubMed ID: 9178671
[TBL] [Abstract][Full Text] [Related]
11. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
12. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer.
Voutilainen M; Sokka T; Juhola M; Farkkilä M; Hannonen P
Scand J Gastroenterol; 1998 Aug; 33(8):811-6. PubMed ID: 9754727
[TBL] [Abstract][Full Text] [Related]
14. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.
ten Wolde S; Dijkmans BA; Janssen M; Hermans J; Lamers CB
Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962
[TBL] [Abstract][Full Text] [Related]
15. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
16. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K
Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813
[TBL] [Abstract][Full Text] [Related]
19. What do we do about Helicobacter pylori?
Hawkey CJ
Can J Gastroenterol; 1999 Mar; 13(2):143-5. PubMed ID: 10203433
[TBL] [Abstract][Full Text] [Related]
20. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori.
Loeb DS; Talley NJ; Ahlquist DA; Carpenter HA; Zinsmeister AR
Gastroenterology; 1992 Jun; 102(6):1899-905. PubMed ID: 1587409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
